Next Stage for Genomics

Sunday Business (London, England), December 3, 2000 | Go to article overview

Next Stage for Genomics


G

ENOMICS may have come close to becoming a household word this year, thanks to the hype that surrounded the contest to produce the first map of the human genome. But the real race - to discover new medicines using this information - has only just begun.

US-based Human Genome Sciences has been at the forefront of this race. Founded in 1992 by former Harvard Medical School professor William Haseltine, today its chairman and chief executive, HGS could bring its first drug to market in the next three to four years.

In Paris last week for the annual healthcare conference run by bank SG Cowen, Haseltine said the key question facing the industry today was how to develop drugs to treat and cure disease.

Unlike many of his competitors, Haseltine argues that the sequencing of the human genome is not a necessary step towards developing new medicines. He says: "Genomic data is very important to understand evolution, but not medicine. The problem we realised from the beginning was that even if you have the genomic sequence, you cannot find a gene unless you have a receptor. In other words, you need messenger RNA (ribo-nucleic acid)."

Rather than relying on the map of the genome and the genes themselves, HGS's method uses this messenger RNA, a substance produced every time a gene becomes active.

HGS's first product, Repifermin, for example, which is likely to be used in the treatment of severe, intractable wounds, is being developed from its analysis of a vast database of different messenger RNAs and associated proteins.

Unlike many of its competitors, HGS has concentrated most of its efforts on extracting genes and their related proteins from the genome using DNA-sequencing technology developed by Craig Venter, Haseltine's former partner and now head of rival Celera Genomics. In the process, it became the first company to isolate a virtually complete set of human genes.

In 1993, Haseltine struck the industry's first genomics-driven deal with SmithKline Beecham when it licensed out its gene database. The deal pioneered the partnerships that have been struck since between companies through the industry.

Today, HGS has already filed patents on more than 11,000 genes and has close to 20 partnerships - the bulk of its revenues comes from colla-borations with big pharmaceutical companies such as SmithKline and Takeda Chemicals of Japan which license the use of its database. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Next Stage for Genomics
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Oops!

    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.